
Sign up to save your podcasts
Or
In this interview, Dr. Dale Bredesen, a neurologist specializing in the treatment of Alzheimer’s, discusses how his team is now launching a new randomized, controlled trial at six sites.
4.6
14391,439 ratings
In this interview, Dr. Dale Bredesen, a neurologist specializing in the treatment of Alzheimer’s, discusses how his team is now launching a new randomized, controlled trial at six sites.
5,015 Listeners
7,147 Listeners
559 Listeners
785 Listeners
379 Listeners
2,257 Listeners
723 Listeners
9,261 Listeners
1,814 Listeners
2,560 Listeners
72 Listeners
725 Listeners
277 Listeners
2,469 Listeners
90 Listeners